Search
Search
Editorially independent content, supported with advertising
Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD
Show Description +
How do you manage a patient who presented with GA prior to FDA approval of a complement inhibitor and whose vision has declined significantly since such a therapy was approved? Sunir Garg, MD, submits a real-world case to moderator Judy Kim, MD, and panelists Rishi Singh, MD, and Deepak Sambhara, MD, which they use as a platform to discuss the link between early treatment and better prognosis, the merits of treating a better-seeing eye in bilateral GA, and the challenges of managing wet AMD alongside GA.
Posted: 6/19/2025
Judy Kim, MD; Sunir Garg, MD; Deepak Sambhara, MD; and Rishi Singh, MD
How do you manage a patient who presented with GA prior to FDA approval of a complement inhibitor and whose vision has declined significantly since such a therapy was approved? Sunir Garg, MD, submits a real-world case to moderator Judy Kim, MD, and panelists Rishi Singh, MD, and Deepak Sambhara, MD, which they use as a platform to discuss the link between early treatment and better prognosis, the merits of treating a better-seeing eye in bilateral GA, and the challenges of managing wet AMD alongside GA.
Posted: 6/19/2025
![[2019] Amniotic Membrane Placement for Repair of Recurrent Macular Hole](https://d33x7gwyb2b5z6.cloudfront.net/eyetube/thumbs/gldaw.jpg?auto=compress,format&w=504)
Please log in to leave a comment.